FIELD: medicine.
SUBSTANCE: invention represents a pharmaceutical composition for treating viral diseases, containing dipeptide, differing by the fact that dipeptide is an aqueous solution of dipeptide of formula (I) Gly-Pro in concentration 0.9-1.1 %; besides, Nipagin is used as a preservative; the ingredients of the composition are taken in certain proportions, g/l.
EFFECT: extended range of the antiviral drugs, more efficient prevention and treatment of viral infection.
3 cl, 5 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ADMINISTRATION OF Arg-Pro-Gly-Pro PEPTIDE AS ANTIVIRAL AGENT FOR ANIMALS | 2009 |
|
RU2414235C1 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| AGENT RAISING SURVIVAL AND ALLEVIATING THE COURSE OF VIRAL INFECTION - EXTROMELIA IN EXPERIMENT | 1992 |
|
RU2043115C1 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST INFLUENZA A AND SARS-CoV-2 VIRUSES | 2022 |
|
RU2796748C1 |
| METHOD OF PREVENTING DISEASE CAUSED BY AVIAN FLU VIRUS | 2008 |
|
RU2395295C2 |
| VACCINE AGAINST INFLUENZA TYPE A, INFLUENZA TYPE B AND COVID-19 | 2021 |
|
RU2751485C1 |
| ANTIVIRAL AGENT | 2014 |
|
RU2564919C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL DISEASES | 2010 |
|
RU2438694C1 |
| STRAIN OF A RECOMBINANT PSEUDO ADENOVIRAL PARTICLE BASED ON HUMAN ADENOVIRUS GENOME OF SEROTYPE 5 Ad5-tetOFF-E3-HA125 SEROTYPE, CARRYING HAEMAGGLUTININ CONSENSUS GENE OF INFLUENZA VIRUS SUBTYPES H1, H2, H5 FOR PRODUCING INFLUENZA IMMUNOGENIC PREPARATIONS, METHOD FOR PRODUCING GENE | 2018 |
|
RU2713722C1 |
| DRUG FOR PREVENTION AND TREATMENT OF INFLUENZA TYPES A AND B | 2008 |
|
RU2380100C1 |
